Dr. John Glod, MD
Claim this profileNational Cancer Institute Pediatric Oncology Branch
Studies Brain Tumor
Studies Soft Tissue Sarcoma
10 reported clinical trials
13 drugs studied
Area of expertise
1Brain Tumor
Stage IV
H3K27M positive
Stage III
2Soft Tissue Sarcoma
Stage IV
HLA-A positive
MAGE-A4 positive
Affiliated Hospitals
Clinical Trials John Glod, MD is currently running
Adoptive Cell Therapy
for Cancer
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
Recruiting1 award Phase 1
Afamitresgene Autoleucel
for Pediatric Cancer
This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
Recruiting1 award Phase 1 & 2
More about John Glod, MD
Clinical Trial Related9 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments John Glod, MD has experience with
- Ivosidenib
- Tipifarnib
- Selpercatinib
- Hydroxychloroquine
- Dabrafenib
- Trametinib
Breakdown of trials John Glod, MD has run
Brain Tumor
Soft Tissue Sarcoma
Low Grade Glioma
Neuroblastoma
Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does John Glod, MD specialize in?
Is John Glod, MD currently recruiting for clinical trials?
Are there any treatments that John Glod, MD has studied deeply?
What is the best way to schedule an appointment with John Glod, MD?
What is the office address of John Glod, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.